Andelyn Biosciences

Columbus, OH
Find alternatives to Andelyn Biosciences for AAV →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
63.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (20) ○ EMA GMP ○ MHRA GMP

Quick Facts: Andelyn Biosciences

Signal Score
63.0/100 (as of 2026-10-29)
Quality Compliance
Assessment pending
Headquarters
Columbus, OH
Website
Modalities
AAV, Lentiviral, Plasmid DNA
Active Programs
No ClinicalTrials.gov matches confirmed — 8 partnership signals in press (announcements, not verified)
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Andelyn Biosciences

Spinout from Nationwide Children's.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 8 partnership announcements found in press monitoring.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Plasmid DNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 68.0
Parent company: Nationwide Children's Hospital spinout
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Nationwide Children's Hospital spinout
Financial assessment: 68.0/100
Capacity 58.0
1 manufacturing site: Columbus, OH
Modalities: AAV, Lentiviral, Plasmid DNA
Capacity assessment: 58.0/100
Sites: Columbus, OH
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
StatusAvailable
1 manufacturing site: Columbus, OH
Modalities: AAV, Lentiviral, Plasmid DNA
Capacity assessment: 58.0/100
Sites: Columbus, OH
Press Signals20 articles (not scored)
1 manufacturing site: Columbus, OH
Modalities: AAV, Lentiviral, Plasmid DNA
Capacity assessment: 58.0/100

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Nov 20, 2026

Company Signals 20 articles

Company announcements, not verified evidence. They do not change any score.
general 2026-10-08
Andelyn Biosciences and PQP Group partner to streamline EU and UK supply pathways for cell and gene therapies - BioSpectrum Asia
Andelyn Biosciences and PQP Group partner to streamline EU and UK supply pathways for cell and gene therapies  BioSpectrum Asia
general 2026-10-08
Andelyn Biosciences, PQP Partner to Streamline EU and UK Supply for CGT Sponsors - Contract Pharma
Andelyn Biosciences, PQP Partner to Streamline EU and UK Supply for CGT Sponsors  Contract Pharma
general 2026-10-06
Andelyn Biosciences and PQP Group Partner to Streamline EU and UK Supply Pathways for Cell and Gene Therapy Sponsors | Newswise - Newswise
Andelyn Biosciences and PQP Group Partner to Streamline EU and UK Supply Pathways for Cell and Gene Therapy Sponsors | Newswise  Newswise
general 2026-04-30
Andelyn Biosciences Targets Gene Therapy Growth Opportunities at ASGCT Meeting - TipRanks
Andelyn Biosciences Targets Gene Therapy Growth Opportunities at ASGCT Meeting  TipRanks
partnership 2026-04-28
ENCell signs partnership with U.S. CGT CDMO Andelyn Biosciences to build integrated production network - 더바이오
ENCell signs partnership with U.S. CGT CDMO Andelyn Biosciences to build integrated production network  더바이오
general 2026-04-26
Andelyn Biosciences Emphasizes Gene and Cell Therapy Focus on National DNA Day - TipRanks
Andelyn Biosciences Emphasizes Gene and Cell Therapy Focus on National DNA Day  TipRanks
partnership 2026-04-25
Andelyn Biosciences Highlights Engagement at Gene Therapy Symposium - TipRanks
Andelyn Biosciences Highlights Engagement at Gene Therapy Symposium  TipRanks
general 2026-04-25
Andelyn Biosciences Expands Global Gene Therapy Reach and Showcases Digital CDMO Capabilities - TipRanks
Andelyn Biosciences Expands Global Gene Therapy Reach and Showcases Digital CDMO Capabilities  TipRanks
general 2026-04-25
Andelyn Biosciences Emphasizes Gene and Cell Therapy Focus on National DNA Day - TipRanks
Andelyn Biosciences Emphasizes Gene and Cell Therapy Focus on National DNA Day  TipRanks
general 2026-04-24
Andelyn Biosciences Highlights Presence at Gene Therapy Symposium - TipRanks
Andelyn Biosciences Highlights Presence at Gene Therapy Symposium  TipRanks
general 2026-04-23
Andelyn Biosciences Highlights Transparency-Focused Dashboard for Gene Therapy CDMO Clients - TipRanks
Andelyn Biosciences Highlights Transparency-Focused Dashboard for Gene Therapy CDMO Clients  TipRanks
general 2026-04-22
Andelyn Biosciences, ENCell Enter Strategic Gene Therapy Manufacturing Pact - Contract Pharma
Andelyn Biosciences, ENCell Enter Strategic Gene Therapy Manufacturing Pact  Contract Pharma
partnership 2026-04-22
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing - BioSpectrum Asia
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing  BioSpectrum Asia
general 2026-04-22
ENCell, Andelyn Biosciences partner to build global gene therapy production network - koreabiomed.com
ENCell, Andelyn Biosciences partner to build global gene therapy production network  koreabiomed.com
partnership 2026-04-22
Andelyn Partners with S. Korea-Based ENCell to Accelerate Global Delivery of Gene Therapies - Genetic Engineering and Biotechnology News
Andelyn Partners with S. Korea-Based ENCell to Accelerate Global Delivery of Gene Therapies  Genetic Engineering and Biotechnology News
partnership 2026-04-22
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing - BioSpectrum Asia
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing  BioSpectrum Asia
partnership 2026-04-22
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing - BioSpectrum Asia
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing  BioSpectrum Asia
general 2026-04-22
ENCell, Andelyn Biosciences partner to build global gene therapy production network - koreabiomed.com
ENCell, Andelyn Biosciences partner to build global gene therapy production network  koreabiomed.com
partnership 2026-04-21
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing - PR Newswire
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing  PR Newswire
partnership 2026-04-21
Andelyn Biosciences Sets Up US–APAC Manufacturing Bridge Through ENCell Partnership - TipRanks
Andelyn Biosciences Sets Up US–APAC Manufacturing Bridge Through ENCell Partnership  TipRanks

Frequently Asked Questions About Andelyn Biosciences

What is Andelyn Biosciences's CDMO Signal Score?
Andelyn Biosciences has a Signal Score of 63/100, based on quality, operations, financial stability, and capacity data.
Evaluating Andelyn Biosciences for a manufacturing program?
Use the free AI matchmaker to compare Andelyn Biosciences against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → Lentiviral CDMOs → Plasmid DNA CDMOs →

Similar CDMOs

Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 77.6
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid, Small Molecule API, Oral Solid Dose, Sterile Fill-Finish
Oxford Biomedica
Oxford, United Kingdom
Signal Score: 76.2
Lentiviral, AAV, Plasmid DNA
Cincinnati Children's Vector Production Facility
Cincinnati, OH
Signal Score: 75.1
AAV, Lentiviral
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC

Compare Andelyn Biosciences with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Andelyn Biosciences
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.